Answer
No. The selected fixed-combination products are licensed for type 2 diabetes. Dapagliflozin alone has additional licensed roles, but these do not extend to the combination tablet.
Sources for this answer
- Dapagliflozin/ Metformin hydrochloride — Current selected SmPCemc · Summary of Product Characteristics
- Xigduo 5 mg/1,000 mg film-coated tablets — Current selected SmPCemc · Summary of Product Characteristics